Trial Outcomes & Findings for Music vs. No Music During Cesarean Delivery on Patient Satisfaction (NCT NCT03412019)
NCT ID: NCT03412019
Last Updated: 2020-03-03
Results Overview
This outcome will be measured using Morgan's "Maternal Satisfaction Scale for Cesarean Section" (MSSCS). It is a 22-item questionnaire, each item have a Likert scale from 1-7 (1 =strongly disagree, 7=strongly agree), yielding a composite (total) score ranging 22-154, representing lowest to highest satisfaction. The questionnaire will be given to participants on post-operative day one during the hours of 8am-1pm.
COMPLETED
NA
22 participants
1 Day
2020-03-03
Participant Flow
Participant milestones
| Measure |
Control Group
no music
|
Intervention Group
Music: selections of Mozart piano sonatas
|
|---|---|---|
|
Overall Study
STARTED
|
11
|
11
|
|
Overall Study
COMPLETED
|
10
|
10
|
|
Overall Study
NOT COMPLETED
|
1
|
1
|
Reasons for withdrawal
| Measure |
Control Group
no music
|
Intervention Group
Music: selections of Mozart piano sonatas
|
|---|---|---|
|
Overall Study
Withdrawal by Subject
|
1
|
1
|
Baseline Characteristics
Patients decided to withdraw from the study prematurely
Baseline characteristics by cohort
| Measure |
Control Group
n=10 Participants
no music
|
Intervention Group
n=10 Participants
Music: selections of Mozart piano sonatas
|
Total
n=20 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
36.2 years
STANDARD_DEVIATION 4.2 • n=39 Participants • Patients decided to withdraw from the study prematurely
|
32.1 years
STANDARD_DEVIATION 6.1 • n=41 Participants • Patients decided to withdraw from the study prematurely
|
34.2 years
STANDARD_DEVIATION 5.5 • n=35 Participants • Patients decided to withdraw from the study prematurely
|
|
Sex: Female, Male
Female
|
10 Participants
n=39 Participants • patients who were not anlayzed withdrew from the study
|
10 Participants
n=41 Participants • patients who were not anlayzed withdrew from the study
|
20 Participants
n=35 Participants • patients who were not anlayzed withdrew from the study
|
|
Sex: Female, Male
Male
|
0 Participants
n=39 Participants • patients who were not anlayzed withdrew from the study
|
0 Participants
n=41 Participants • patients who were not anlayzed withdrew from the study
|
0 Participants
n=35 Participants • patients who were not anlayzed withdrew from the study
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=39 Participants • those who withdrew early were not analyzed
|
0 Participants
n=41 Participants • those who withdrew early were not analyzed
|
0 Participants
n=35 Participants • those who withdrew early were not analyzed
|
|
Race (NIH/OMB)
Asian
|
0 Participants
n=39 Participants • those who withdrew early were not analyzed
|
1 Participants
n=41 Participants • those who withdrew early were not analyzed
|
1 Participants
n=35 Participants • those who withdrew early were not analyzed
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=39 Participants • those who withdrew early were not analyzed
|
0 Participants
n=41 Participants • those who withdrew early were not analyzed
|
0 Participants
n=35 Participants • those who withdrew early were not analyzed
|
|
Race (NIH/OMB)
Black or African American
|
0 Participants
n=39 Participants • those who withdrew early were not analyzed
|
0 Participants
n=41 Participants • those who withdrew early were not analyzed
|
0 Participants
n=35 Participants • those who withdrew early were not analyzed
|
|
Race (NIH/OMB)
White
|
6 Participants
n=39 Participants • those who withdrew early were not analyzed
|
6 Participants
n=41 Participants • those who withdrew early were not analyzed
|
12 Participants
n=35 Participants • those who withdrew early were not analyzed
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=39 Participants • those who withdrew early were not analyzed
|
0 Participants
n=41 Participants • those who withdrew early were not analyzed
|
0 Participants
n=35 Participants • those who withdrew early were not analyzed
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
4 Participants
n=39 Participants • those who withdrew early were not analyzed
|
3 Participants
n=41 Participants • those who withdrew early were not analyzed
|
7 Participants
n=35 Participants • those who withdrew early were not analyzed
|
PRIMARY outcome
Timeframe: 1 DayThis outcome will be measured using Morgan's "Maternal Satisfaction Scale for Cesarean Section" (MSSCS). It is a 22-item questionnaire, each item have a Likert scale from 1-7 (1 =strongly disagree, 7=strongly agree), yielding a composite (total) score ranging 22-154, representing lowest to highest satisfaction. The questionnaire will be given to participants on post-operative day one during the hours of 8am-1pm.
Outcome measures
| Measure |
Control Group
n=10 Participants
no music
|
Intervention Group
n=10 Participants
Music: selections of Mozart piano sonatas
|
|---|---|---|
|
Patient Satisfaction
|
120 units on a scale
Standard Deviation 22.3
|
116 units on a scale
Standard Deviation 16.4
|
SECONDARY outcome
Timeframe: PerioperativelyChange in anxiety before and after surgery using a numeric rating scale from 0 (no anxiety at all) to 10 (greatest anxiety)
Outcome measures
| Measure |
Control Group
n=10 Participants
no music
|
Intervention Group
n=10 Participants
Music: selections of Mozart piano sonatas
|
|---|---|---|
|
Patient Anxiety
|
2.5 NRS scale (0-10)
Standard Deviation 2.6
|
2.7 NRS scale (0-10)
Standard Deviation 2.7
|
SECONDARY outcome
Timeframe: post procedureThis is the post-procedure mean arterial pressure of the patients.
Outcome measures
| Measure |
Control Group
n=10 Participants
no music
|
Intervention Group
n=10 Participants
Music: selections of Mozart piano sonatas
|
|---|---|---|
|
Hemodynamic Parameter (Mean Arterial Pressure, MAP)
|
82.2 mmHg
Standard Deviation 24.8
|
80.4 mmHg
Standard Deviation 8.4
|
Adverse Events
Control Group
Intervention Group
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place